+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH) - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH) - Global Clinical Trials Review, 2025

  • Clinical Trials
  • October 2025
  • 807 Pages
  • Global
From
Reflux Esophagitis (Gastroesophageal Reflux Disease) - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Reflux Esophagitis (Gastroesophageal Reflux Disease) - Global Clinical Trials Review, 2025

  • Clinical Trials
  • October 2025
  • 1457 Pages
  • Global
From
Hypoglycemia: Market View - Product Thumbnail Image

Hypoglycemia: Market View

  • Report
  • October 2025
  • 88 Pages
  • Global
From
IDWeek 2025: Pre-Conference Coverage - Product Thumbnail Image

IDWeek 2025: Pre-Conference Coverage

  • Report
  • October 2025
  • 15 Pages
  • Global
From
Huntington's Disease: Opportunity Assessment and Forecast - Product Thumbnail Image

Huntington's Disease: Opportunity Assessment and Forecast

  • Report
  • October 2025
  • 84 Pages
  • Global
From
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD or NAFLD) - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD or NAFLD) - Global Clinical Trials Review, 2025

  • Clinical Trials
  • September 2025
  • 855 Pages
  • Global
From
Epilepsy - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Epilepsy - Global Clinical Trials Review, 2025

  • Clinical Trials
  • September 2025
  • 2081 Pages
  • Global
From
Hemophilia A (Factor VIII Deficiency) - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Hemophilia A (Factor VIII Deficiency) - Global Clinical Trials Review, 2025

  • Clinical Trials
  • September 2025
  • 473 Pages
  • Global
From
Huntington Disease - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Huntington Disease - Global Clinical Trials Review, 2025

  • Clinical Trials
  • September 2025
  • 195 Pages
  • Global
From
Alopecia Areata: Opportunity Assessment and Forecast to 2033 - Update - Product Thumbnail Image

Alopecia Areata: Opportunity Assessment and Forecast to 2033 - Update

  • Report
  • September 2025
  • 81 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis: Epidemiology Forecast to 2034 - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis: Epidemiology Forecast to 2034

  • Report
  • September 2025
  • 27 Pages
  • Global
From
Age-Related Macular Degeneration: Epidemiology Forecast to 2034 - Product Thumbnail Image

Age-Related Macular Degeneration: Epidemiology Forecast to 2034

  • Report
  • September 2025
  • 54 Pages
  • Global
From
Amyloidosis - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Amyloidosis - Global Clinical Trials Review, 2025

  • Clinical Trials
  • August 2025
  • 349 Pages
  • Global
From
Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, 2025

  • Clinical Trials
  • August 2025
  • 1403 Pages
  • Global
From
Hyperglycemia - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Hyperglycemia - Global Clinical Trials Review, 2025

  • Clinical Trials
  • August 2025
  • 334 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis - Global Clinical Trials Review, 2025

  • Clinical Trials
  • August 2025
  • 551 Pages
  • Global
From
Inflammatory Bowel Disease - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Inflammatory Bowel Disease - Global Clinical Trials Review, 2025

  • Clinical Trials
  • August 2025
  • 2906 Pages
  • Global
From
Gaucher Disease - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Gaucher Disease - Global Clinical Trials Review, 2025

  • Clinical Trials
  • August 2025
  • 139 Pages
  • Global
From
Chronic Hepatitis B (CHB): Epidemiology Forecast to 2034 - Product Thumbnail Image

Chronic Hepatitis B (CHB): Epidemiology Forecast to 2034

  • Report
  • August 2025
  • 54 Pages
  • Global
From
Eosinophilic Esophagitis (EoE): Opportunity Assessment and Forecast - Update - Product Thumbnail Image

Eosinophilic Esophagitis (EoE): Opportunity Assessment and Forecast - Update

  • Report
  • August 2025
  • 66 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more